VORAPAXAR for Myocardial infarction: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 10 adverse event reports in the FDA FAERS database where VORAPAXAR was used for Myocardial infarction.
Most Reported Side Effects for VORAPAXAR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Gastrointestinal haemorrhage | 15 | 7.9% | 1 | 7 |
| Epistaxis | 11 | 5.8% | 0 | 1 |
| Chest pain | 8 | 4.2% | 0 | 4 |
| Death | 8 | 4.2% | 8 | 0 |
| Drug dose omission | 8 | 4.2% | 0 | 1 |
| Haemorrhage | 7 | 3.7% | 0 | 2 |
| Dyspnoea | 6 | 3.2% | 0 | 4 |
| Haemoglobin decreased | 5 | 2.7% | 0 | 3 |
| Malaise | 5 | 2.7% | 1 | 1 |
| Rash | 5 | 2.7% | 0 | 1 |
Other Indications for VORAPAXAR
Product used for unknown indication (41)
Peripheral arterial occlusive disease (30)
Coronary artery disease (22)
Cardiovascular event prophylaxis (7)
Peripheral vascular disorder (5)
Other Drugs Used for Myocardial infarction
TICAGRELOR (2,988)
CLOPIDOGREL BISULFATE (1,365)
ATORVASTATIN (785)
ASPIRIN (736)
RAMIPRIL (312)
METOPROLOL (291)
BISOPROLOL (261)
PRASUGREL (245)
EVOLOCUMAB (227)
ROSUVASTATIN (206)